Logo image of CRNC

CERENCE INC (CRNC) Stock Fundamental Analysis

NASDAQ:CRNC - US1567271093 - Common Stock

9.64 USD
+0.38 (+4.08%)
Last: 9/9/2025, 7:53:20 PM
9.63 USD
-0.01 (-0.1%)
After Hours: 9/9/2025, 7:53:20 PM
Fundamental Rating

3

Taking everything into account, CRNC scores 3 out of 10 in our fundamental rating. CRNC was compared to 280 industry peers in the Software industry. There are concerns on the financial health of CRNC while its profitability can be described as average. CRNC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CRNC had positive earnings in the past year.
CRNC had a positive operating cash flow in the past year.
In the past 5 years CRNC reported 4 times negative net income.
CRNC had a positive operating cash flow in 4 of the past 5 years.
CRNC Yearly Net Income VS EBIT VS OCF VS FCFCRNC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.05%, CRNC is in line with its industry, outperforming 46.43% of the companies in the same industry.
CRNC has a Return On Equity of -16.55%. This is comparable to the rest of the industry: CRNC outperforms 43.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.79%, CRNC is in the better half of the industry, outperforming 62.14% of the companies in the same industry.
Industry RankSector Rank
ROA -4.05%
ROE -16.55%
ROIC 0.79%
ROA(3y)-37.21%
ROA(5y)-22.01%
ROE(3y)-156.16%
ROE(5y)-93.19%
ROIC(3y)N/A
ROIC(5y)N/A
CRNC Yearly ROA, ROE, ROICCRNC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

CRNC's Operating Margin of 2.16% is fine compared to the rest of the industry. CRNC outperforms 63.93% of its industry peers.
In the last couple of years the Operating Margin of CRNC has grown nicely.
CRNC's Gross Margin of 70.76% is in line compared to the rest of the industry. CRNC outperforms 56.43% of its industry peers.
CRNC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.16%
PM (TTM) N/A
GM 70.76%
OM growth 3Y-6.27%
OM growth 5Y3.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y1.84%
CRNC Yearly Profit, Operating, Gross MarginsCRNC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

CRNC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CRNC has been increased compared to 1 year ago.
CRNC has more shares outstanding than it did 5 years ago.
CRNC has a worse debt/assets ratio than last year.
CRNC Yearly Shares OutstandingCRNC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CRNC Yearly Total Debt VS Total AssetsCRNC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -0.95, we must say that CRNC is in the distress zone and has some risk of bankruptcy.
CRNC has a Altman-Z score of -0.95. This is in the lower half of the industry: CRNC underperforms 74.29% of its industry peers.
CRNC has a debt to FCF ratio of 4.77. This is a neutral value as CRNC would need 4.77 years to pay back of all of its debts.
The Debt to FCF ratio of CRNC (4.77) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.28 is on the high side and indicates that CRNC has dependencies on debt financing.
CRNC has a Debt to Equity ratio of 1.28. This is in the lower half of the industry: CRNC underperforms 77.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 4.77
Altman-Z -0.95
ROIC/WACC0.08
WACC9.62%
CRNC Yearly LT Debt VS Equity VS FCFCRNC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.77 indicates that CRNC should not have too much problems paying its short term obligations.
CRNC has a Current ratio (1.77) which is comparable to the rest of the industry.
CRNC has a Quick Ratio of 1.75. This is a normal value and indicates that CRNC is financially healthy and should not expect problems in meeting its short term obligations.
CRNC's Quick ratio of 1.75 is in line compared to the rest of the industry. CRNC outperforms 56.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.75
CRNC Yearly Current Assets VS Current LiabilitesCRNC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

The earnings per share for CRNC have decreased strongly by -54.96% in the last year.
The earnings per share for CRNC have been decreasing by -23.41% on average. This is quite bad
CRNC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.20%.
The Revenue has been growing slightly by 1.79% on average over the past years.
EPS 1Y (TTM)-54.96%
EPS 3Y-23.41%
EPS 5YN/A
EPS Q2Q%-36.84%
Revenue 1Y (TTM)-31.2%
Revenue growth 3Y-5.05%
Revenue growth 5Y1.79%
Sales Q2Q%-11.77%

3.2 Future

Based on estimates for the next years, CRNC will show a very strong growth in Earnings Per Share. The EPS will grow by 26.55% on average per year.
The Revenue is expected to decrease by -5.50% on average over the next years.
EPS Next Y-60.09%
EPS Next 2Y-28.52%
EPS Next 3Y-18.96%
EPS Next 5Y26.55%
Revenue Next Year-24.02%
Revenue Next 2Y-10.75%
Revenue Next 3Y-5.5%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRNC Yearly Revenue VS EstimatesCRNC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CRNC Yearly EPS VS EstimatesCRNC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.34, the valuation of CRNC can be described as correct.
CRNC's Price/Earnings ratio is rather cheap when compared to the industry. CRNC is cheaper than 81.79% of the companies in the same industry.
When comparing the Price/Earnings ratio of CRNC to the average of the S&P500 Index (27.07), we can say CRNC is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.41, CRNC is valued correctly.
Based on the Price/Forward Earnings ratio, CRNC is valued cheaply inside the industry as 83.57% of the companies are valued more expensively.
CRNC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.59.
Industry RankSector Rank
PE 16.34
Fwd PE 16.41
CRNC Price Earnings VS Forward Price EarningsCRNC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRNC is valued a bit cheaper than 73.21% of the companies in the same industry.
94.64% of the companies in the same industry are more expensive than CRNC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.01
EV/EBITDA 32.42
CRNC Per share dataCRNC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CRNC's earnings are expected to decrease with -18.96% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-28.52%
EPS Next 3Y-18.96%

0

5. Dividend

5.1 Amount

CRNC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CERENCE INC

NASDAQ:CRNC (9/9/2025, 7:53:20 PM)

After market: 9.63 -0.01 (-0.1%)

9.64

+0.38 (+4.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-19 2025-11-19/amc
Inst Owners77.25%
Inst Owner Change-7.5%
Ins Owners5.47%
Ins Owner Change0.23%
Market Cap417.60M
Analysts74.55
Price Target11.99 (24.38%)
Short Float %20.25%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)133.76%
Min EPS beat(2)84.96%
Max EPS beat(2)182.56%
EPS beat(4)4
Avg EPS beat(4)109.32%
Min EPS beat(4)81.16%
Max EPS beat(4)182.56%
EPS beat(8)7
Avg EPS beat(8)98.37%
EPS beat(12)11
Avg EPS beat(12)104.54%
EPS beat(16)13
Avg EPS beat(16)79.82%
Revenue beat(2)2
Avg Revenue beat(2)6.35%
Min Revenue beat(2)1.42%
Max Revenue beat(2)11.28%
Revenue beat(4)3
Avg Revenue beat(4)5.9%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)12.76%
Revenue beat(8)7
Avg Revenue beat(8)5.37%
Revenue beat(12)10
Avg Revenue beat(12)4.42%
Revenue beat(16)10
Avg Revenue beat(16)2.78%
PT rev (1m)1.29%
PT rev (3m)1.44%
EPS NQ rev (1m)-23.43%
EPS NQ rev (3m)-1475.49%
EPS NY rev (1m)29.31%
EPS NY rev (3m)31.39%
Revenue NQ rev (1m)-3.9%
Revenue NQ rev (3m)-5.13%
Revenue NY rev (1m)2.13%
Revenue NY rev (3m)2.13%
Valuation
Industry RankSector Rank
PE 16.34
Fwd PE 16.41
P/S 1.7
P/FCF 10.01
P/OCF 7.66
P/B 2.68
P/tB N/A
EV/EBITDA 32.42
EPS(TTM)0.59
EY6.12%
EPS(NY)0.59
Fwd EY6.09%
FCF(TTM)0.96
FCFY9.99%
OCF(TTM)1.26
OCFY13.06%
SpS5.68
BVpS3.59
TBVpS-3.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.05%
ROE -16.55%
ROCE 1%
ROIC 0.79%
ROICexc 0.93%
ROICexgc 2.78%
OM 2.16%
PM (TTM) N/A
GM 70.76%
FCFM 16.97%
ROA(3y)-37.21%
ROA(5y)-22.01%
ROE(3y)-156.16%
ROE(5y)-93.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y38.84%
ROICexcg growth 5Y29.35%
ROICexc growth 3Y39.52%
ROICexc growth 5Y37.04%
OM growth 3Y-6.27%
OM growth 5Y3.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y1.84%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 4.77
Debt/EBITDA 12.12
Cap/Depr 115.38%
Cap/Sales 5.2%
Interest Coverage 0.95
Cash Conversion 332.31%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.75
Altman-Z -0.95
F-Score4
WACC9.62%
ROIC/WACC0.08
Cap/Depr(3y)50.56%
Cap/Depr(5y)51.08%
Cap/Sales(3y)2.85%
Cap/Sales(5y)3.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.96%
EPS 3Y-23.41%
EPS 5YN/A
EPS Q2Q%-36.84%
EPS Next Y-60.09%
EPS Next 2Y-28.52%
EPS Next 3Y-18.96%
EPS Next 5Y26.55%
Revenue 1Y (TTM)-31.2%
Revenue growth 3Y-5.05%
Revenue growth 5Y1.79%
Sales Q2Q%-11.77%
Revenue Next Year-24.02%
Revenue Next 2Y-10.75%
Revenue Next 3Y-5.5%
Revenue Next 5YN/A
EBIT growth 1Y-91.13%
EBIT growth 3Y-11%
EBIT growth 5Y5.05%
EBIT Next Year-43.25%
EBIT Next 3Y-3.74%
EBIT Next 5Y31.94%
FCF growth 1Y372.79%
FCF growth 3Y-41.96%
FCF growth 5Y-31.95%
OCF growth 1Y726.85%
OCF growth 3Y-38.63%
OCF growth 5Y-27.87%